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Case Report
Mycobacterium fortuitum Peritonitis in a Patient Undergoing
Continuous Ambulatory Peritoneal Dialysis
Takashi Ando, Munekazu Ryuzaki, Michiko Handa, Tsunejiro Sekita, Takashi Sakurai1
We report here one case of Mycobacterium fortuitum peritonitis in a patient undergoing continuous ambulatory
peritoneal dialysis (CAPD). Owing to scarce clinical findings specific for this infection, the catheter was
removed and CAPD abandoned. Clinicians must consider this type of organism if refractory peritonitis is
encountered. Precise and prompt diagnosis and commencement of adequate antibiotic(s) may alter the prognosis
of this disease. [Hong Kong J Nephrol 2003;5(2):101–4]
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INTRODUCTION
Recent advances in disconnecting technology have
greatly reduced the incidence of peritonitis in patients
undergoing continuous ambulatory peritoneal dialysis
(CAPD). Although many cases of successful treatment
have been reported recently [1–3], both mycobacterial
and fungal peritonitis represent troublesome
complications and they remain major and serious
problems for both patients and clinicians. Encapsulating
peritoneal sclerosis (EPS) is a late complication in
CAPD patients that is also a worrisome and unsolved
problem [4]. It has not been fully elucidated how
refractory peritonitis contributes to EPS.
Several cases of Mycobacterium fortuitum
peritonitis associated with CAPD have been described
since 1983 [5]. Owing to the difficulty in early diagnosis
and prompt commencement of adequate antimicrobial
agents, catheter removal has been recommended to date
[5,6]. Here, we report the case of a Japanese CAPD
patient who suffered from M. fortuitum peritonitis,
treated by  catheter removal, and who recovered with
no symptoms of EPS.
CASE REPORT
A 59-year-old Japanese male patient was found to have
chronic renal failure due to glomerulonephritis in 1994.
He was started on hemodialysis in August 2001, at the
age of 66 years, when he was uremic and severely
malnourished. Due to patient preference, hemodialysis
was stopped in the same month and CAPD was
commenced. He was admitted to hospital on November
24, 2001 with complaints of cloudy peritoneal dialysis
fluid and weight gain.
On admission, his body temperature was 37.3$C and
his body weight was 10 kg above his dry weight. His
serum C-reactive protein (CRP) was 0.176 g/L (normal
range, < 0.004 g/L) and serum albumin level was 22 g/L
(normal range, 36–50 g/L). He had suffered from a fever
for a week prior to admission. He was edematous but
showed no abdominal tenderness. There was no
complaint of severe abdominal pain either before or
during admission.
He was treated with intraperitoneal ceftazidime
1 g/1.5 L daily. Clinically, his condition improved.
Repeated cultures, including those for acid-fast bacilli,
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showed no organisms. On the third hospital day,
however, due to poor peritoneal fluid outflow,
hemodialysis was started and antimicrobial peritoneal
i r r iga t ion  (wi th  gentamic in)  and  sys temic
administration (with piperacillin) were carried out.
As the peritoneal catheter was enwrapped by the
omentum (Figure 1), it was laparoscopically released
on day 16 after admission. After the second
encapsulation and inability to withdraw fluid, the
catheter was removed and CAPD was abandoned. There
was no positive growth from the peritoneal fluids until
the removal of the Tenckhoff catheter.
Ten days after catheter removal, acid-fast bacilli of
unknown species were cultured from the pulled-out
catheter specimen. As the patient was considered to be
immunocompromised, in that he had received
hemodialysis and had potentially been exposed to
tuberculosis (due to the presence of a tuberculosis unit
in the same district), he was started on anti-tuberculosis
therapy (isoniazid, ethambutol, rifampicin).
After the anti-tuberculosis therapy, M. fortuitum
was identified by electro-microscopic examination
(Figure 2) and mycobacterial culture. Following the
results of drug resistance testing, the anti-tuberculosis
treatment was changed to levofloxacin for 2 months.
He was also given prednisolone for 6 months to prevent
peritoneal sclerosis. After commencement of sensitive
chemotherapy, CRP and erythrocyte sedimentation rate
improved. Follow-up abdominal computed tomography
(CT) scan revealed no sign of EPS and the patient is
now on long-term hemodialysis.
DISCUSSION
M. fortuitum peritonitis was first reported by Pulliam
et al [5]. However, since there have not been many
cases reported [5,7–13], to date, there are no definite
symptoms specific for M. fortuitum peritonitis
(Table). As this infection is not well known to
clinicians, early diagnosis is difficult and it can easily
develop into refractory peritonitis. All the reported
cases were difficult to diagnose and catheter removal
was required to treat the infection. In general,
prognosis is worse than for infections caused by other
bacteria.
M. fortuitum is the commonest of the group IV
(Runyon’s classification), rapidly growing, non-
tuberculous mycobacteria. It is easily isolated from
environmental sources, e.g. soil, dust, water [14]. It does
not usually cause human infection, but catheter insertion
or the presence of a foreign body may result in clinical
symptoms [15].
In our patient, the abdominal wall closed after
catheter removal and we could not isolate the same
Figure 1. Encapsulation of the catheter by the omentum.
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M. fortuitum peritonitis in a CAPD patient
Table. Mycobacterium fortuitum peritonitis.
Case Reference Age/Sex Race Etiology On admission History of Past history Fever Abdominal Other PD- PMN
CAPD of peritonitis tenderness  symptoms WBC (%)
(n/mm3)
1 Pulliam et al, 57/M Caucasian DM 8-day history of 3 mo NA No No None 6,700 82
1983 [5] cloudy dialysate
2 Woods et al, 32/M Caucasian Unknown Confusion and 7 mo 4 Yes No 37.5$C 3,845 83
1986 [7] visual
hallucination
3 LaRocco et al 15/M Caucasian Unknown Persistent 2 yr NA Yes Yes Yes 173 92
1986 [8] peritonitis
4 Soriano et al, 42/M Spanish DM type I NA 18 mo 6 NA NA Yes 980 NA
1989 [9]
5 Soriano et al, 40/M Spanish DM Stroke 17 mo 0 Yes Yes Yes 130 NA
1989 [9]
6 Kolmos et al, 35/M Danish CGN Unsuccessful 10 mo 4 NA NA Yes NA NA
1992 [10] renal transplant
7 Vera & Lew, 33/M Caucasian Horseshoe Mild abdominal NA NA NA Yes NA NA NA
1999 [11] kidney discomfort
8 Vera & Lew, 71/F Caucasian DM Vascular NA NA Yes Yes Yes NA NA
1999 [11] insufficiency
of the lower
extremities
9 Youmbissi 45/F Arab Unknown Tunnel 3 yr NA Yes No Weight NA NA
et al, 2001 infection loss
[12]
10 Osada et al, 67/F Japanese Unknown Peritonitis 7 yr NA Yes Yes NA 5,000– NA
2001 [13] 6,000
11 Ando et al, 66/M Japanese CGN Cloudy 4 mo 0 Yes No Weight 5,650 89.4
2003 dialysate gain
[present study]
CAPD = continuous ambulatory peritoneal dialysis; PD-WBC = peritoneal dialysate white blood cell count; PMN = polymorphonuclear
leukocytes; DM = diabetes mellitus; CGN = chronic glomerulonephritis; NA = not available.
Figure 2. Electro-microscopic examination of the catheter (inner
surface).
organism again. As we did not detect the organism
earlier and his peritonitis was refractory to treatment,
catheter removal was necessary, as is often the case
with this type of infection. With the electro-microscopic
morphologic analysis, we believe that this episode of
peritonitis was caused by M. fortuitum. Some
antibiotics can be used against this organism, thus,
earlier diagnosis may have changed the standard
therapeutic protocol.
Polymerase chain reaction (PCR) can quickly
identify tuberculosis. Hidaka et al reported that they
can detect and identify mycobacteria other than
tuberculosis by using the PCR restriction fragment
length polymorphism method [16]. M. fortuitum
infection, however, is very rare and rarely suspected
because it shows no specific clinical symptoms. White
et al reported several cases of non-tuberculous
mycobacterial peritonitis during CAPD [1] and
described their clinical features, but there were only
four cases of M. fortuitum and its description is not
necessarily satisfactory. Some advocate prophylactic
antibiotic therapy for this organism, but the value of
this is unknown as M. fortuitum is resistant to many
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drugs. For better therapy, clinical reports, including this
case, must be accumulated.
The pathogenesis of EPS has not been fully
elucidated, but refractory peritonitis is known to be a
predisposing cause [4]. Although EPS-like symptoms
after M. fortuitum peritonitis have been reported [13],
whether it contributes to EPS or not is uncertain. In
our patient, for whom 2 months of antibiotic therapy
was prescribed, we also decided to give 6 months of
steroid therapy. Further careful observation is required,
although there were no abnormal findings in the early
follow-up abdominal CT scan and laboratory data.
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